PEMETREXED INTAS pemetrexed (as disodium) 1000 mg powder for injection vial

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

pemetrexed disodium, Quantity: 1102.9 mg (Equivalent: pemetrexed, Qty 1000 mg)

Prieinama:

Accord Healthcare Pty Ltd

INN (Tarptautinis Pavadinimas):

pemetrexed disodium

Vaisto forma:

Injection, powder for

Sudėtis:

Excipient Ingredients: mannitol; sodium hydroxide; hydrochloric acid

Vartojimo būdas:

Intravenous

Vienetai pakuotėje:

1 vial per carton

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell lung Cancer,Pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,Pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Produkto santrauka:

Visual Identification: A white to either light yellow or greenish yellow lyophilized solid in a clear glass vial; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2015-05-28